CVE-2015-3459

highEPSS 0.051 · 92 %ileEURUUS
grimoire priorityP2 · Scheduled
Exploitable?
—
no known exploitation
Likely / severe?
5.06% (92nd) EPSS
CVSS 10 · high
Is it mine?
7 products
Check your exposure
Who says so?
5 sources
cnnvd · enisa_euvd · fstec_bdu · cisa_csaf_ot

EPSS · scored 2026-10-20

The communication module on the Hospira LifeCare PCA Infusion System before 7.0 does not require authentication for root TELNET sessions, which allows remote attackers to modify the pump configuration via unspecified commands.

01

remediations

Vendor fix, mitigation, or workaround guidance, as published by each source.

No vendor fix yet; a mitigation is available.

  • MitigationLifeCare PCA Infusion Systemcisa_csaf_ot

    CS-CERT has been working with Hospira since May 2014 to address the vulnerabilities in the LifeCare PCA Infusion System. Hospira has developed a new version of the PCS Infusion System, Version 7.0 that addresses the identified vulnerabilities. According to Hospira, Version 7.0 has Port 20/FTP and Port 23/TELNET closed by default to prevent unauthorized access. Existing PCA Infusion Systems running Version 5.0 can be upgraded to Version 7.0 when it becomes available. Hospira’s Version 7.0 is being reviewed by the FDA prior to its release. The release date for Version 7.0 of the LifeCare PCA Infusion System has not been determined. For additional information about Hospira’s new release, contact Hospira’s technical support at 1‑800-241-4002. ICS-CERT encourages asset owners to take defensive measures to protect against this and other cybersecurity risks.

  • MitigationLifeCare PCA Infusion Systemcisa_csaf_ot

    Existing PCA Infusion Systems running Version 5.0 can be upgraded to Version 7.0 when it becomes available. Hospira will be retiring older versions of the LifeCare PCA Infusion System, Versions 2 and Versions 3, by the end of the year, 2015.

02

cvss

Technical severity, 0–10. One row per scoring source.

10.0
010

base score 0–10 · higher = more severe · hover a vector to decode⚠ sources disagree · high–critical · 8.5–10

v2.010highAV:N/AC:L/Au:N/C:C/I:C/A:Cprimary · NVD / NIST USexploitability 10 · impact 10
v2.010criticalAV:N/AC:L/Au:N/C:C/I:C/A:Csecondary · CISA US
v2.010criticalAV:N/AC:L/Au:N/C:C/I:C/A:Csecondary · FSTEC (BDU) RU
v2.08.5highAV:N/AC:L/Au:N/C:C/I:C/A:C/E:Usecondary · CVSS-BT (t0sche)
03

weaknesses

The CWE weakness classes this flaw belongs to.

CWE-264USprimaryCWE-264USCWE-285US
04

affected products (7)

Products and version ranges known to be affected.

05

advisories (2)

Vendor and ecosystem advisories describing this.

  • ICSA-15-125-01Hospira LifeCare PCA Infusion System Vulnerabilities2015-02-05icsa · cisa_csaf_otUS

    This CSAF advisory was extracted from unstructured data and may contain inaccuracies. If you notice any errors, please reach out to the designated contact at CISA CSAF: central@cisa.dhs.gov

  • ICSA-15-125-01BHospira LifeCare PCA Infusion System Vulnerabilities2015-02-05icsa · cisa_csaf_otUS

    This CSAF advisory was extracted from unstructured data and may contain inaccuracies. If you notice any errors, please reach out to the designated contact at CISA CSAF: central@cisa.dhs.gov

06

also known as (4)

Other names and identifiers for this entity.

07

sources

Which sources assert this record, and when.

cnnvdenisa_euvdfstec_bducisa_csaf_otnvdNVDCVE.orgMITRE
published 2015-04-29modified 2026-06-17
09

references (21)

External citations — patches, advisories, analysis.

scry

Attackers weaponise vulnerabilities like this against internet-exposed services. See what is exposed on your perimeter with a free passive scan.

Free scan